← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
enCore Energy's uranium revenue and cash generation weakened as production investment continued, while material weaknesses and recurring losses keep the ramp financially demanding.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 26.0%Watch
- Profitability — The net loss narrowed from $61.392M to $56.856MOK
- Cash flow — Free cash flow remained negative, with the outflow narrowing from $56.552M to $44.989MOK
- Margins — Operating margin contracted 2865 bps to -152.39%Watch
- Accounting — Production ramp with unresolved controlsWatch
- Insiders — 6 purchases and 10 salesOK
Business
enCore Energy develops and operates U.S. in-situ-recovery uranium projects, led by South Texas production assets and a broader development portfolio.
Leadership changes
From enCore Energy Corp.'s own filings, the day they're filed.
- Robert J. Willette · Chief Executive Officer · departureeff. 2026-04-20
- Richard Little · Chief Executive Officer · appointmenteff. 2026-04-20
- William M. Sheriff · director · departureeff. 2026-03-02
Latest filings
- 10-Q · Quarterly report2026-08-13
- 8-K · Company announcement2026-08-13
- 8-K · Company announcement2026-07-09
- 8-K · Company announcement2026-06-16
- 8-K · Company announcement2026-05-14
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about enCore Energy Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.